No article text was recorded for this version.
tumor-specific epigenetic biomarkers
Version 1 of 115 papers19 conceptsfrozen 2026-10-04
Papers in this version
- Blog: Absence of cyclin D2 expression is associated with promoter hypermethylation in gastric cancer
- Blog: Frequent epigenetic inactivation of secreted frizzled-related protein 2 (SFRP2) by promoter methylation in human gastric cancer
- Blog: Assessment of PAX1 and JAM3 methylation triage efficacy across HPV genotypes and age groups in high-risk HPV-positive women in China
- Blog: Potential diagnostic and prognostic values of detecting promoter hypermethylation in the serum of patients with gastric cancer
- Blog: Fibulin 1 is downregulated through promoter hypermethylation in gastric cancer
- Blog: Cytological DNA methylation for cervical cancer screening: a validation set
- Blog: CDHu40: a novel marker gene set of neuroendocrine prostate cancer
- Blog: BRCA1 & BRCA2 methylation as a prognostic and predictive biomarker in cancer: Implementation in liquid biopsy in the era of precision medicine
- Blog: Machine learning unveils an immune-related DNA methylation profile in germline DNA from breast cancer patients
- Blog: DLEC1 is a functional 3p22.3 tumour suppressor silenced by promoter CpG methylation in colon and gastric cancers
- Blog: Cell-Free Circulating Methylated SEPT9 for Noninvasive Diagnosis and Monitoring of Colorectal Cancer
- Blog: MethylPurify: tumor purity deconvolution and differential methylation detection from single tumor DNA methylomes
- Blog: Value of circulating free DNA methylation in the diagnosis of esophageal cancer: A systematic review and meta‑analysis
- Blog: Hypermethylated CDO1 and CELF4 in cytological specimens as triage strategy biomarkers in endometrial malignant lesions
- Blog: Circulating let-7f-5p improve risk prediction of prostate cancer in patients with benign prostatic hyperplasia
History & citation
Current · Permanent link
- This direction split from Epigenetic Liquid Biopsies for Non-Invasive Cancer Detection (67% overlap)
Cite this direction
Latest version (a living page):
@misc{lacuna_tumor_specific_epigenetic_biomarkers_36aef993,
title = {tumor-specific epigenetic biomarkers},
author = {{Lacuna}},
howpublished = {Lacuna research direction},
year = {2026},
url = {https://lacuna.tiptreesystems.com/direction/tumor-specific-epigenetic-biomarkers/rdr_36aef9939aaa475b84a5635bea89a642},
note = {Latest version of a living research direction; cite a version for a fixed text. Accessed 2026-11-20},
}This exact version (version 1, frozen text):
@misc{lacuna_tumor_specific_epigenetic_biomarkers_36aef993_v1,
title = {tumor-specific epigenetic biomarkers},
author = {{Lacuna}},
howpublished = {Lacuna research direction},
year = {2026},
url = {https://lacuna.tiptreesystems.com/direction/tumor-specific-epigenetic-biomarkers/rdr_36aef9939aaa475b84a5635bea89a642/v/1},
note = {Version 1, frozen 2026-10-04. Accessed 2026-11-20},
}